pioneer 6 oral semaglutide cardiovascular outcomes trial results Frontiers Post hoc analysis of SUSTAIN

Trials with older GLP-1 drugs (liraglutide, exenatide) including the large ADJUNCT ONE and ADJUNCT TWO studies showed modest HbA1c improvements of 0.10.7%, meaningful weight loss, and lower insulin requirements, but also raised early concerns about hypoglycemia and ketosis that kept enthusiasm in check for years

Peptide therapy addresses a wide range of perimenopausal and menopausal symptoms by bringing about hormonal balance, tissue repair, and reducing inflammation

Youll notice better texture and lasting radiance

Its Too Expensive : Lets face it, GLP-1 medications like Zepbound and Wegovy are pricey, and insurance companies dont want to pay for it